文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

体温异常对严重脓毒症集束化治疗实施及结局的影响:聚焦急性呼吸窘迫综合征、脓毒症与创伤急诊救治结局研究的回顾性子分析

Impact of Body Temperature Abnormalities on the Implementation of Sepsis Bundles and Outcomes in Patients With Severe Sepsis: A Retrospective Sub-Analysis of the Focused Outcome Research on Emergency Care for Acute Respiratory Distress Syndrome, Sepsis and Trauma Study.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论严重脓毒症患者入ICU时低体温(<36°C)与疾病严重度更高、住院死亡率风险更高(OR 1.760)及脓毒症集束化治疗实施率更低相关。

该研究为聚焦急性呼吸窘迫综合征、脓毒症与创伤急诊救治结局研究的回顾性子分析,纳入日本59个ICU的1143例严重脓毒症(Sepsis-2标准)成人患者,按入ICU时核心体温分为<36°C、36-38°C、>38°C三组。低体温(<36°C)占11.1%,该组患者年龄更大、BMI更低、脓毒性休克患病率更高,APACHE II和SOFA评分更高。低体温组3小时集束化治疗整体实施率及广谱抗生素给药率显著低于>38°C组;低体温组住院死亡率相对>38°C组的OR为1.760(95%CI 1.134-2.732)。低体温组无ICU天数和无呼吸机天数也显著更少。

要点

  • 严重脓毒症患者入ICU时低体温(<36°C)占11.1%(127/1143),该组年龄更大、BMI更低、脓毒性休克患病率更高,APACHE II和SOFA评分更高。
  • 低体温组住院死亡率相对体温>38°C组的OR为1.760(95%CI 1.134-2.732)。
  • 低体温组3小时集束化治疗整体实施率及广谱抗生素给药率显著低于体温>38°C组。
  • 低体温组无ICU天数和无呼吸机天数显著少于其他体温组。
  • 三组间住院死亡率和28天死亡率差异显著。

适用人群与场景

  • 日本59个ICU中,2016年1月至2017年3月收治的基于Sepsis-2标准诊断的严重脓毒症成人患者。

诊断标准与关键阈值

  • 基于Sepsis-2标准诊断严重脓毒症。
  • 按入ICU时核心体温分为三组:<36°C、36-38°C、>38°C。

研究设计与关键结果

  • 研究类型:回顾性子分析;样本量1143例;日本59个ICU;人群为严重脓毒症成人患者;无干预。
  • 低体温(<36°C)占11.1%(127例),36-38°C组565例,>38°C组451例。
  • 低体温组较36-38°C或>38°C组年龄显著更大,BMI更低,脓毒性休克患病率高于>38°C组;入组当日APACHE II和SOFA评分显著更高。
  • 3小时集束化治疗整体实施率及广谱抗生素给药率在三组间显著不同,低体温组显著低于>38°C组。
  • 3小时复苏集束化治疗整体实施率+血管加压药使用+乳酸复测率在三组间显著不同。
  • 住院死亡率和28天死亡率在三组间显著不同;低体温组相对>38°C组的住院死亡OR为1.760(95%CI 1.134-2.732)。
  • 无ICU天数和无呼吸机天数在三组间显著不同,低体温组显著更少。

证据类型、等级与局限

  • 证据类型:回顾性子分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为低体温与显著更高的疾病严重度、死亡风险及更低的脓毒症集束化治疗实施率相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the impact of body temperature on disease severity, implementation of sepsis bundles, and outcomes in severe sepsis patients.

DESIGN: Retrospective sub-analysis.

SETTING: Fifty-nine ICUs in Japan, from January 2016 to March 2017.

PATIENTS: Adult patients with severe sepsis based on Sepsis-2 were enrolled and divided into three categories (body temperature < 36°C, 36-38°C, > 38°C), using the core body temperature at ICU admission.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Compliance with the bundles proposed in the Surviving Sepsis Campaign Guidelines 2012, in-hospital mortality, disposition after discharge, and the number of ICU and ventilator-free days were evaluated. Of 1,143 enrolled patients, 127, 565, and 451 were categorized as having body temperature less than 36°C, 36-38°C, and greater than 38°C, respectively. Hypothermia-body temperature less than 36°C-was observed in 11.1% of patients. Patients with hypothermia were significantly older than those with a body temperature of 36-38°C or greater than 38°C and had a lower body mass index and higher prevalence of septic shock than those with body temperature greater than 38°C. Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment scores on the day of enrollment were also significantly higher in hypothermia patients. Implementation rates of the entire 3-hour bundle and administration of broad-spectrum antibiotics significantly differed across categories; implementation rates were significantly lower in patients with body temperature less than 36°C than in those with body temperature greater than 38°C. Implementation rate of the entire 3-hour resuscitation bundle + vasopressor use + remeasured lactate significantly differed across categories, as did the in-hospital and 28-day mortality. The odds ratio for in-hospital mortality relative to the reference range of body temperature greater than 38°C was 1.760 (95% CI, 1.134-2.732) in the group with hypothermia. The proportions of ICU-free and ventilator-free days also significantly differed between categories and were significantly smaller in patients with hypothermia.

CONCLUSIONS: Hypothermia was associated with a significantly higher disease severity, mortality risk, and lower implementation of sepsis bundles.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kushimoto S, Abe T, Ogura H, et al. Impact of Body Temperature Abnormalities on the Implementation of Sepsis Bundles and Outcomes in Patients With Severe Sepsis: A Retrospective Sub-Analysis of the Focused Outcome Research on Emergency Care for Acute Respiratory Distress Syndrome, Sepsis and Trauma Study. Crit Care Med. 2019. PMID: 30789402. doi:10.1097/CCM.0000000000003688

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。